» Articles » PMID: 16611920

Linkage of Reduced Receptor Affinity and Superinfection to Pathogenesis of TR1.3 Murine Leukemia Virus

Overview
Journal J Virol
Date 2006 Apr 14
PMID 16611920
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

TR1.3 is a Friend murine leukemia virus (MLV) that induces selective syncytium induction (SI) of brain capillary endothelial cells (BCEC), intracerebral hemorrhage, and death. Syncytium induction by TR1.3 has been mapped to a single tryptophan-to-glycine conversion at position 102 of the envelope glycoprotein (Env102). The mechanism of SI by TR1.3 was examined here in comparison to the non-syncytium-inducing, nonpathogenic MLV FB29, which displays an identical BCEC tropism. Envelope protein expression and stability on both infected cells and viral particles were not statistically different for TR1.3 and FB29. However, affinity measurements derived using purified envelope receptor binding domain (RBD) revealed a reduction of >1 log in the K(D) of TR1.3 RBD relative to FB29 RBD. Whole-virus particles pseudotyped with TR1.3 Env similarly displayed a markedly reduced binding avidity compared to FB29-pseudotyped viral particles. Lastly, decreased receptor affinity of TR1.3 Env correlated with the failure to block superinfection following acute and chronic infection by TR1.3. These results definitively show that acquisition of a SI phenotype can be directly linked to amino acid changes in retroviral Env that decrease receptor affinity, thereby emphasizing the importance of events downstream of receptor binding in the cell fusion process and pathology.

Citing Articles

Unique Structure and Distinctive Properties of the Ancient and Ubiquitous Gamma-Type Envelope Glycoprotein.

Hogan V, Johnson W Viruses. 2023; 15(2).

PMID: 36851488 PMC: 9967133. DOI: 10.3390/v15020274.


Unique N-linked glycosylation of CasBrE Env influences its stability, processing, and viral infectivity but not its neurotoxicity.

Renszel K, Traister R, Lynch W J Virol. 2013; 87(15):8372-87.

PMID: 23698308 PMC: 3719805. DOI: 10.1128/JVI.00392-13.


Second site mutation in the virus envelope expands the host range of a cytopathic variant of Moloney murine leukemia virus.

Ferrarone J, Knoper R, Li R, Kozak C Virology. 2012; 433(1):7-11.

PMID: 22835818 PMC: 3444676. DOI: 10.1016/j.virol.2012.06.031.


A mutant retroviral receptor restricts virus superinfection interference and productive infection.

Liu M, Eiden M Retrovirology. 2012; 9:51.

PMID: 22691439 PMC: 3418563. DOI: 10.1186/1742-4690-9-51.


Naturally Occurring Polymorphisms of the Mouse Gammaretrovirus Receptors CAT-1 and XPR1 Alter Virus Tropism and Pathogenicity.

Kozak C Adv Virol. 2012; 2011:975801.

PMID: 22312361 PMC: 3265322. DOI: 10.1155/2011/975801.


References
1.
Battini J, Kayman S, Pinter A, Heard J, Danos O . Role of N-linked glycosylation in the activity of the Friend murine leukemia virus SU protein receptor-binding domain. Virology. 1994; 202(1):496-9. DOI: 10.1006/viro.1994.1369. View

2.
Hudson T, Church D, Greenaway S, Nguyen H, Cook A, Steen R . A radiation hybrid map of mouse genes. Nat Genet. 2001; 29(2):201-5. DOI: 10.1038/ng1001-201. View

3.
Kalyanaraman V, Sarngadharan M, Gallo R . Characterization of Rauscher murine leukemia virus envelope glycoprotein receptor in membranes from murine fibroblasts. J Virol. 1978; 28(3):686-96. PMC: 525792. DOI: 10.1128/JVI.28.3.686-696.1978. View

4.
Ganguly K, Kalyanaraman V, Sarngadharan M . Analysis of the interaction between Rauscher murine leukemia virus and murine cell membrane receptor by in vitro binding assay. Cancer Lett. 1983; 18(1):79-86. DOI: 10.1016/0304-3835(83)90120-9. View

5.
Lavillette D, Boson B, Russell S, Cosset F . Activation of membrane fusion by murine leukemia viruses is controlled in cis or in trans by interactions between the receptor-binding domain and a conserved disulfide loop of the carboxy terminus of the surface glycoprotein. J Virol. 2001; 75(8):3685-95. PMC: 114860. DOI: 10.1128/JVI.75.8.3685-3695.2001. View